Alan Venook, MD
Professor
Medicine
School of Medicine

Dr. Venook is a Medical Oncologist with expertise in Gastrointestinal cancers. He leads that program in the UCSF Helen Diller Family Comprehensive Cancer Center. The program boasts a robust clinical trials portfolio primarily for patients in need of new options.

Awards

Show all (5) Hide

• Giant of Cancer Care in GI Oncology, Giants of Cancer Care, 2019
• Heroes of Hope Award, Colon Cancer Alliance, 2017
• NCCN Board of Producers Award, National Comprehensive Cancer Network, 2013
• Service Excellence Award, Healthnetwork Foundation, 2011
• Director's Service Award, National Cancer Institute, 2010

Education & Training

Show all (2) Hide

• M.D. Medicine University of California, San Francisco 1980
• Residency School of Medicine University of California, San Francisco

Websites

Show all (2) Hide

• Clinical Profile at UCSF Medical Center (ucsfhealth.org)
• Profile at UCSF Cancer Center (cancer.ucsf.edu)

Grants and Projects

Show all (3) Hide

• Cancer Center Support Grant, NIH, 1999-2023
• General Clinical Research Center, NIH, 1974-2009
• Cancer and Leukemia Group B, NIH, 1993-2003

Publications (324)

Top publication keywords:
Colorectal NeoplasmsCarcinoma, HepatocellularAdenocarcinomaLeucovorinAntineoplastic AgentsLiver NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsCetuximabBevacizumabBiomarkers, TumorRectal NeoplasmsColonic NeoplasmsFluorouracilMedical OncologyCamptothecin

• q-Diffusion leverages the full dimensionality of gene coexpression in single-cell transcriptomics.
  Communications biology 2024 Marmarelis MG, Littman R, Battaglin F, Niedzwiecki D, Venook A, Ambite JL, Galstyan A, Lenz HJ, Ver Steeg G
• Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies.
  Research square 2024 Yazdani A, Yazdani A, Mendez-Giraldez R, Pillonetto G, Samiei E, Hadi R, Lenz HJ, Venook A, Samiei A, Nixon A, Lucci J, Kopetz S, Bertagnolli M, Perou C, Innocenti F
• HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 Battaglin F, Ou FS, Qu X, Hochster HS, Niedzwiecki D, Goldberg RM, Mayer RJ, Ashouri K, Zemla TJ, Blanke CD, Venook AP, Kabbarah O, Lenz HJ, Innocenti F
• CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.
  Cancer research communications 2024 Abou-Alfa GK, Geyer SM, Nixon AB, Innocenti F, Shi Q, Kumthekar P, Jacobson S, El Dika I, Yaqubie A, Lopez J, Huang B, Tang YW, Wen Y, Schwartz LH, El-Khoueiry AB, Knox JJ, Rajdev L, Bertagnolli MM, …
• Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.
  The oncologist 2024 Keenan BP, Sibley A, Zhang L, Westring AF, Velazquez AI, Bank EM, Bergsland EK, Boreta L, Conroy P, Daras M, Hermiston M, Hsu G, Paris PL, Piawah S, Sinha S, Sosa JA, Tsang M, Venook AP, Wong M, Yom …

Show all (319 more) Hide

• Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
  European journal of cancer (Oxford, England : 1990) 2024 Arai H, Yang Y, Baca Y, Millstein J, Denda T, Ou FS, Innocenti F, Takeda H, Kubota Y, Doi A, Horie Y, Umemoto K, Izawa N, Wang J, Battaglin F, Jayachandran P, Algaze S, Soni S, Zhang W, Goldberg RM, …
• CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value.
  Journal for immunotherapy of cancer 2024 Battaglin F, Baca Y, Millstein J, Yang Y, Xiu J, Arai H, Wang J, Ou FS, Innocenti F, Mumenthaler SM, Jayachandran P, Kawanishi N, Lenz A, Soni S, Algaze S, Zhang W, Khoukaz T, Roussos Torres E, Seeber…
• Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy.
  Research square 2023 Yazdani A, Lenz HJ, Pillonetto G, Mendez-Giraldez R, Yazdani A, Sanof H, Hadi R, Samiei E, Venook AP, Ratain MJ, Rashid N, Vincent BG, Qu X, Wen Y, Kosorok M, Symmans WF, Shen JPYC, Lee MS, Kopetz S, …
• Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
  medRxiv : the preprint server for health sciences 2023 Quintanilha JCF, Sibley AB, Liu Y, Niedzwiecki D, Halabi S, Rogers L, O'Neil B, Kindler H, Kelly W, Venook A, McLeod HL, Ratain MJ, Nixon AB, Innocenti F, Owzar K
• DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Innocenti F, Mu W, Qu X, Ou FS, Kabbarah O, Blanke CD, Venook AP, Lenz HJ, Rashid NU
• Associations between the Gut Microbiota, Race, and Ethnicity of Patients with Colorectal Cancer: A Pilot and Feasibility Study.
  Cancers 2023 Piawah S, Kyaw TS, Trepka K, Stewart AL, Mora RV, Stanfield D, Levine K, Van Blarigan EL, Venook A, Turnbaugh PJ, Nguyen T, Atreya CE
• Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
  Cancer 2023 Brown JC, Ma C, Shi Q, Zemla T, Couture F, Kuebler P, Kumar P, Tan B, Krishnamurthi S, Chang V, Goldberg RM, Venook AP, Blanke CD, O'Reilly EM, Shields AF, Meyerhardt JA
• Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.
  Cancers 2023 Ou FS, Ahn DH, Dixon JG, Grothey A, Lou Y, Kasi PM, Hubbard JM, Van Cutsem E, Saltz LB, Schmoll HJ, Goldberg RM, Venook AP, Hoff P, Douillard JY, Hecht JR, Hurwitz H, Punt CJA, Koopman M, Bokemeyer C,…
• Variety of Fruit and Vegetables and Alcohol Intake are Associated with Gut Microbial Species and Gene Abundance in Colorectal Cancer Survivors.
  The American journal of clinical nutrition 2023 Kyaw TS, Upadhyay V, Tolstykh I, Van Loon K, Laffan A, Stanfield D, Gempis D, Kenfield SA, Chan JM, Piawah S, Atreya CE, Ng K, Venook A, Kidder W, Turnbaugh PJ, Van Blarigan EL
• Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance).
  Clinical cancer research : an official journal of the American Association for Cancer Research 2023 Wang QL, Ma C, Yuan C, Shi Q, Wolpin BM, Zhang Y, Fuchs CS, Meyer J, Zemla T, Cheng E, Kumthekar P, Guthrie KA, Couture F, Kuebler P, Kumar P, Tan B, Krishnamurthi S, Goldberg RM, Venook A, Blanke C, …
• Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2023 Liu VN, Zuniga KB, Paciorek A, Zhang L, Chan JM, Carroll PR, Van Loon K, Laffan A, Venook A, Van Blarigan EL, Kenfield SA
• Flashback Foreword: IFL/FOLFOX/IROX in Advanced Colorectal Cancer and FOLFIRI and FOLFOX6 in Colorectal Cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Venook AP
• NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
  Journal of the National Comprehensive Cancer Network : JNCCN 2023 Benson AB, D'Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, Anders R, Are C, Bachini M, Binder D, Borad M, Bowlus C, Brown D, Burgoyne A, Castellanos J, Chahal P, Cloyd J, Covey AM, Glazer ES, …
• Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Basch E, Dueck AC, Mitchell SA, Mamon H, Weiser M, Saltz L, Gollub M, Rogak L, Ginos B, Mazza GL, Colgrove B, Chang G, Minasian L, Denicoff A, Thanarajasingam G, Musher B, George T, Venook A, Farma J,…
• Preoperative Treatment of Locally Advanced Rectal Cancer.
  The New England journal of medicine 2023 Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL, Goldberg J, Al Baghdadi T, Goodman KA, McWilliams RR, Farma JM, George TJ, Kennecke HF, Shergill A, Montemurro M, Nelson GD, Colgrove B, …
• Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2023 Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Hecht JR, Hoffe S, Hubbard J, Hunt S, Hussan H, Jeck W, Johung KL, Joseph N, …
• Neoadjuvant Immunotherapy for Colorectal Cancer: Too Good to Be True?
  JCO oncology practice 2023 Venook AP
• Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinoma.
  The journal of sexual medicine 2023 Savoie MB, Paciorek A, Van Loon K, Anwar M, Atreya CE, Johnson PC, Kenfield SA, Laffan A, Levin AO, Smith JF, Stanfield D, Venook A, Zhang L, Van Blarigan EL, Rowen T
• Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data.
  NPJ precision oncology 2023 Zack T, Losert KP, Maisel SM, Wild J, Yaqubie A, Herman M, Knox JJ, Mayer RJ, Venook AP, Butte A, O'Neill AF, Abou-Alfa GK, Gordan JD
• Quality of life among colorectal cancer survivors participating in a pilot randomized controlled trial of a web-based dietary intervention with text messages.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2023 Wang L, Langlais C, Kenfield SA, Van Loon K, Laffan A, Atreya CE, Chan JM, Zhang L, Allen IE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP, Van Blarigan EL
• Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.
  BMC cancer 2022 Fidelman N, Atreya CE, Griffith M, Milloy MA, Carnevale J, Cinar P, Venook AP, Van Loon K
• Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Lee S, Ma C, Shi Q, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Lewis D, Tan B, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF, Meyerhardt JA
• Association between adherence to the American Cancer Society Nutrition and Physical Activity Guidelines and stool frequency among colon cancer survivors: a cohort study.
  Journal of cancer survivorship : research and practice 2022 Greenberg AL, Tolstykh IV, Van Loon K, Laffan A, Stanfield D, Steiding P, Kenfield SA, Chan JM, Atreya CE, Piawah S, Kidder W, Venook AP, Van Blarigan EL, Varma MG
• Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
  Annals of surgical oncology 2022 Kemeny MM, Zhao F, Forastiere AA, Catalano P, Hamilton SR, Miedema BW, Dawson NA, Weiner LM, Smith BD, Mason BA, Graziano SL, Gilman PB, Venook AP, Pinto HA, Whitehead RP, O'Dwyer PJ, Benson AB
• Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2022 Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Gunn A, Hecht JR, Hoffe S, Hubbard J, Hunt S, Jeck W, Johung KL, Kirilcuk N, …
• Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism.
  Nature microbiology 2022 Spanogiannopoulos P, Kyaw TS, Guthrie BGH, Bradley PH, Lee JV, Melamed J, Malig YNA, Lam KN, Gempis D, Sandy M, Kidder W, Van Blarigan EL, Atreya CE, Venook A, Gerona RR, Goga A, Pollard KS, Turnbaugh…
• ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer.
  Nature communications 2022 Johnson RM, Qu X, Lin CF, Huw LY, Venkatanarayan A, Sokol E, Ou FS, Ihuegbu N, Zill OA, Kabbarah O, Wang L, Bourgon R, de Sousa E Melo F, Bolen C, Daemen A, Venook AP, Innocenti F, Lenz HJ, Bais C
• Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance).
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Raghav K, Ou FS, Venook AP, Innocenti F, Sun R, Lenz HJ, Kopetz S
• Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.
  JAMA oncology 2022 Katz MHG, Shi Q, Meyers J, Herman JM, Chuong M, Wolpin BM, Ahmad S, Marsh R, Schwartz L, Behr S, Frankel WL, Collisson E, Leenstra J, Williams TM, Vaccaro G, Venook A, Meyerhardt JA, O'Reilly EM
• Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405.
  International journal of cancer 2022 Van Blarigan EL, Ma C, Ou FS, Bainter TM, Venook AP, Ng K, Niedzwiecki D, Giovannucci E, Lenz HJ, Polite BN, Hochster HS, Goldberg RM, Mayer RJ, Blanke CD, O'Reilly EM, Ciombor KK, Meyerhardt JA
• Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).
  Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Nixon AB, Sibley AB, Liu Y, Hatch AJ, Jiang C, Mulkey F, Starr MD, Brady JC, Niedzwiecki D, Venook AP, Baez-Diaz L, Lenz HJ, O'Neil BH, Innocenti F, Meyerhardt JA, O'Reilly EM, Owzar K, Hurwitz HI
• Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance).
  Endocrine-related cancer 2022 Kulke MH, Ou FS, Niedzwiecki D, Huebner L, Kunz P, Kennecke HF, Wolin EM, Chan JA, O'Reilly EM, Meyerhardt JA, Venook A
• Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Innocenti F, Yazdani A, Rashid N, Qu X, Ou FS, Van Buren S, Bertagnolli MM, Kabbarah O, Blanke CD, Venook AP, Lenz HJ, Vincent BG
• Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
  Journal of the National Cancer Institute 2022 Lipsyc-Sharf M, Zhang S, Ou FS, Ma C, McCleary NJ, Niedzwiecki D, Chang IW, Lenz HJ, Blanke CD, Piawah S, Van Loon K, Bainter TM, Venook AP, Mayer RJ, Fuchs CS, Innocenti F, Nixon AB, Goldberg R, O'…
• Colorectal Cancer Surveillance With Circulating Tumor DNA Assay.
  JAMA network open 2022 Venook AP
• Quality of life of colorectal cancer survivors participating in a pilot randomized controlled trial of physical activity trackers and daily text messages.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022 Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya C, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP, Van Blarigan EL
• Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer.
  JAMA network open 2022 Van Blarigan EL, Ou FS, Bainter TM, Fuchs CS, Niedzwiecki D, Zhang S, Saltz LB, Mayer RJ, Hantel A, Benson AB, Atienza D, Messino M, Kindler HL, Venook AP, Ogino S, Sanoff HK, Giovannucci EL, Ng K, …
• Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.
  Journal of gastrointestinal oncology 2022 Yothers G, Venook AP, Oki E, Niedzwiecki D, Lin Y, Crager MR, Chao C, Baehner FL, Wolmark N, Yoshino T
• Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis.
  Journal of geriatric oncology 2022 McCleary NJ, Zhang S, Ma C, Ou FS, Bainter TM, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Ng K, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs …
• Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years.
  European journal of cancer (Oxford, England : 1990) 2022 Papamichael D, Lopes GS, Olswold CL, Douillard JY, Adams RA, Maughan TS, Van Cutsem E, Venook AP, Lenz HJ, Heinemann V, Kaplan R, Bokemeyer C, Chibaudel B, Grothey A, Yoshino T, Zalcberg J, De Gramont…
• Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II).
  JMIR cancer 2022 Van Blarigan EL, Dhruva A, Atreya CE, Kenfield SA, Chan JM, Milloy A, Kim I, Steiding P, Laffan A, Zhang L, Piawah S, Fukuoka Y, Miaskowski C, Hecht FM, Kim MO, Venook AP, Van Loon K
• Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
  Journal of the National Cancer Institute 2021 Yin J, Cohen R, Jin Z, Liu H, Pederson L, Adams R, Grothey A, Maughan TS, Venook A, Van Cutsem E, Punt C, Koopman M, Falcone A, Tebbutt NC, Seymour MT, Bokemeyer C, Rubio ED, Kaplan R, Heinemann V, …
• Being Present 2.0: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and Caregivers.
  Global advances in health and medicine 2021 Dragomanovich HM, Dhruva A, Ekman E, Schoenbeck KL, Kubo A, Van Blarigan EL, Borno HT, Esquivel M, Chee B, Campanella M, Philip EJ, Rettger JP, Rosenthal B, Van Loon K, Venook AP, Boscardin C, Moran P…
• Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer.
  Oncogene 2021 Arai H, Elliott A, Millstein J, Xiu J, Ou FS, Innocenti F, Wang J, Battaglin F, Jayachandran P, Kawanishi N, Soni S, Zhang W, Sohal D, Goldberg RM, Hall MJ, Scott AJ, Khushman M, Hwang JJ, Lou E, …
• Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
  International journal of cancer 2021 Quintanilha JCF, Wang J, Sibley AB, Xu W, Espin-Garcia O, Jiang C, Etheridge AS, Ratain MJ, Lenz HJ, Bertagnolli M, Kindler HL, Dickler MN, Venook A, Liu G, Owzar K, Lin D, Innocenti F
• BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database.
  Journal of the National Cancer Institute 2021 Cohen R, Liu H, Fiskum J, Adams R, Chibaudel B, Maughan TS, Van Cutsem E, Venook A, Douillard JY, Heinemann V, Ja Punt C, Falcone A, Bokemeyer C, Kaplan R, Lenz HJ, Koopman M, Yoshino T, Zalcberg J, …
• Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.
  Liver cancer 2021 Kelley RK, Joseph NM, Nimeiri HS, Hwang J, Kulik LM, Ngo Z, Behr SC, Onodera C, Zhang K, Bocobo AG, Benson AB, Venook AP, Gordan JD
• Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931).
  Cancer 2021 Snyder RA, He J, Le-Rademacher J, Ou FS, Dodge AB, Zemla TJ, Paskett ED, Chang GJ, Innocenti F, Blanke C, Lenz HJ, Polite BN, Venook AP
• Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis.
  Therapeutic advances in medical oncology 2021 Yin J, Dawood S, Cohen R, Meyers J, Zalcberg J, Yoshino T, Seymour M, Maughan T, Saltz L, Van Cutsem E, Venook A, Schmoll HJ, Goldberg R, Hoff P, Hecht JR, Hurwitz H, Punt C, Diaz Rubio E, Koopman M, …
• Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Goodman KA, Ou FS, Hall NC, Bekaii-Saab T, Fruth B, Twohy E, Meyers MO, Boffa DJ, Mitchell K, Frankel WL, Niedzwiecki D, Noonan A, Janjigian YY, Thurmes PJ, Venook AP, Meyerhardt JA, O'Reilly EM, …
• Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2021 Benson AB, D'Angelica MI, Abbott DE, Anaya DA, Anders R, Are C, Bachini M, Borad M, Brown D, Burgoyne A, Chahal P, Chang DT, Cloyd J, Covey AM, Glazer ES, Goyal L, Hawkins WG, Iyer R, Jacob R, Kelley …
• Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance).
  JNCI cancer spectrum 2021 Lee S, Zhang S, Ma C, Ou FS, Wolfe EG, Ogino S, Niedzwiecki D, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Gross CP, Irwin ML, Meyerhardt JA…
• Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
  JAMA 2021 Meyerhardt JA, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Kumthekar P, Guthrie KA, Couture F, Kuebler P, Bendell JC, Kumar P, Lewis D, Tan B, Bertagnolli M, Grothey A, Hochster HS, Goldberg RM,…
• Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2021 Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Farkas L, Garrido-Laguna I, Grem JL, Gunn A, Hecht JR, Hoffe S, Hubbard J, Hunt S, Johung KL, Kirilcuk …
• Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Abraham JP, Magee D, Cremolini C, Antoniotti C, Halbert DD, Xiu J, Stafford P, Berry DA, Oberley MJ, Shields AF, Marshall JL, Salem ME, Falcone A, Grothey A, Hall MJ, Venook AP, Lenz HJ, Helmstetter A…
• Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer.
  JAMA oncology 2020 Mackintosh C, Yuan C, Ou FS, Zhang S, Niedzwiecki D, Chang IW, O'Neil BH, Mullen BC, Lenz HJ, Blanke CD, Venook AP, Mayer RJ, Fuchs CS, Innocenti F, Nixon AB, Goldberg RM, O'Reilly EM, Meyerhardt JA, …
• Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance).
  Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Innocenti F, Sibley AB, Patil SA, Etheridge AS, Jiang C, Ou FS, Howell SD, Plummer SJ, Casey G, Bertagnolli MM, McLeod HL, Auman JT, Blanke CD, Furukawa Y, Venook AP, Kubo M, Lenz HJ, Parker JS, …
• IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
  JNCI cancer spectrum 2020 Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Pollak MN, Nixon AB, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Benson AB, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, …
• Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.
  Molecular therapy : the journal of the American Society of Gene Therapy 2020 Ko AH, Jordan AC, Tooker E, Lacey SF, Chang RB, Li Y, Venook AP, Tempero M, Damon L, Fong L, O'Hara MH, Levine BL, Melenhorst JJ, Plesa G, June CH, Beatty GL
• ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.
  Nature reviews. Clinical oncology 2020 Dasari A, Morris VK, Allegra CJ, Atreya C, Benson AB, Boland P, Chung K, Copur MS, Corcoran RB, Deming DA, Dwyer A, Diehn M, Eng C, George TJ, Gollub MJ, Goodwin RA, Hamilton SR, Hechtman JF, Hochster…
• NCCN Guidelines Insights: Rectal Cancer, Version 6.2020.
  Journal of the National Comprehensive Cancer Network : JNCCN 2020 Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Gunn A, Hoffe S, Hubbard J, Hunt S, Kirilcuk N, Krishnamurthi S, Messersmith…
• Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients.
  The oncologist 2020 Susko M, Wang CJ, Lazar AA, Kim S, Laffan A, Feng M, Ko A, Venook AP, Atreya CE, Van Loon K, Anwar M
• A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.
  The oncologist 2020 El Dika I, Mayer RJ, Venook AP, Capanu M, LaQuaglia MP, Kobos R, O'Neill AF, Chou JF, Ly M, Ang C, O'Reilly EM, Gordan JD, Abou-Alfa GK
• Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405.
  JNCI cancer spectrum 2020 Guercio BJ, Zhang S, Venook AP, Ou FS, Niedzwiecki D, Lenz HJ, Innocenti F, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, …
• Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
  The oncologist 2020 Abou-Alfa GK, Mayer R, Venook AP, O'Neill AF, Beg MS, LaQuaglia M, Kingham PT, Kobos R, Basturk O, Brennan C, Yopp A, Harding JJ, Leong S, Crown J, Hoti E, Leonard G, Ly M, Bradley M, Valentino E, …
• Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer.
  The oncologist 2020 Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K
• Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Van Blarigan EL, Kenfield SA, Chan JM, Van Loon K, Paciorek A, Zhang L, Chan H, Savoie MB, Bocobo AG, Liu VN, Wong LX, Laffan A, Atreya CE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP
• Heated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence.
  Clinical colorectal cancer 2020 Snyder RA, Fournier K, Royal R, Venook AP, Chang GJ
• Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation.
  Journal of gastrointestinal cancer 2019 Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K
• Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial.
  JAMA oncology 2019 Abou-Alfa GK, Shi Q, Knox JJ, Kaubisch A, Niedzwiecki D, Posey J, Tan BR, Kavan P, Goel R, Lammers PE, Bekaii-Saab TS, Tam VC, Rajdev L, Kelley RK, El Dika I, Zemla T, Potaracke RI, Balletti J, El-…
• Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance).
  JNCI cancer spectrum 2019 Brown JC, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Denlinger CS, Atkins JN, Goldberg RM, Ng K, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, …
• Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).
  Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Yuan C, Sato K, Hollis BW, Zhang S, Niedzwiecki D, Ou FS, Chang IW, O'Neil BH, Innocenti F, Lenz HJ, Blanke CD, Goldberg RM, Venook AP, Mayer RJ, Fuchs CS, Meyerhardt JA, Ng K
• Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2019 Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen SA, Cooper HS, Deming DA, Garrido-Laguna I, Grem JL, Hoffe SE, Hubbard J, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, …
• Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.
  Cancer 2019 Lowery MA, Goff LW, Keenan BP, Jordan E, Wang R, Bocobo AG, Chou JF, O'Reilly EM, Harding JJ, Kemeny N, Capanu M, Griffin AC, McGuire J, Venook AP, Abou-Alfa GK, Kelley RK
• Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.
  Cancer 2019 Piawah S, Venook AP
• Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Sato K, Ng K, Van Blarigan E, Mayer RJ, Blanke CD, O'…
• Vitamin D Levels in Patients with Colorectal Cancer and Matched Household Members.
  Journal of clinical nutrition and food science 2019 Savoie MB, Paciorek A, Zhang L, Sommovilla N, Venook AP, Van Blarigan EL, Van Loon K
• High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma.
  PloS one 2019 Donner DB, Nakakura EK, Venook AP, Lenz HJ, Zhang W, Hwang J, Bergsland EK, Lin MH, Toriguchi K, Antonia RJ, Warren RS
• Reply to S. Sorscher.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Innocenti F, Ou FS, Qu X, Zemla T, Niedzwiecki D, Tam R, Mahajan S, Goldberg RM, Bertagnolli MM, Blanke CD, Sanoff H, Atkins J, Polite B, Venook AP, Lenz HJ, Kabbarah O
• RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.
  JCI insight 2019 Gbenedio OM, Bonnans C, Grun D, Wang CY, Hatch AJ, Mahoney MR, Barras D, Matli M, Miao Y, Garcia KC, Tejpar S, Delorenzi M, Venook AP, Nixon AB, Warren RS, Roose JP, Depeille P
• Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance).
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Lenz HJ, Ou FS, Venook AP, Hochster HS, Niedzwiecki D, Goldberg RM, Mayer RJ, Bertagnolli MM, Blanke CD, Zemla T, Qu X, Wirapati P, Tejpar S, Innocenti F, Kabbarah O
• Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
  Journal of the National Comprehensive Cancer Network : JNCCN 2019 Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park…
• Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Innocenti F, Ou FS, Qu X, Zemla TJ, Niedzwiecki D, Tam R, Mahajan S, Goldberg RM, Bertagnolli MM, Blanke CD, Sanoff H, Atkins J, Polite B, Venook AP, Lenz HJ, Kabbarah O
• Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial.
  BMC cancer 2019 Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP
• Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance).
  Journal of the National Cancer Institute 2019 Morales-Oyarvide V, Yuan C, Babic A, Zhang S, Niedzwiecki D, Brand-Miller JC, Sampson-Kent L, Ye X, Li Y, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, …
• Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance).
  Clinical trials (London, England) 2019 Schrag D, Weiser M, Saltz L, Mamon H, Gollub M, Basch E, Venook A, Shi Q
• Genetic variation determines VEGF-A plasma levels in cancer patients.
  Scientific reports 2018 Innocenti F, Jiang C, Sibley AB, Etheridge AS, Hatch AJ, Denning S, Niedzwiecki D, Shterev ID, Lin J, Furukawa Y, Kubo M, Kindler HL, Auman JT, Venook AP, Hurwitz HI, McLeod HL, Ratain MJ, Gordan R, …
• Of Microbes and Microsatellites.
  Cancer immunology research 2018 Atreya CE, Venook AP
• A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors.
  Molecular cancer therapeutics 2018 Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, Wang Y, Nakakura EK
• The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.
  PloS one 2018 Innocenti F, Owzar K, Jiang C, Etheridge AS, Gordân R, Sibley AB, Mulkey F, Niedzwiecki D, Glubb D, Neel N, Talamonti MS, Bentrem DJ, Seiser E, Yeh JJ, Van Loon K, McLeod H, Ratain MJ, Kindler HL, …
• Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers.
  PloS one 2018 Atreya CE, Kubo A, Borno HT, Rosenthal B, Campanella M, Rettger JP, Joseph G, Allen IE, Venook AP, Altschuler A, Dhruva A
• Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance).
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2018 Van Blarigan EL, Ou FS, Niedzwiecki D, Zhang S, Fuchs CS, Saltz L, Mayer RJ, Venook A, Ogino S, Song M, Benson A, Hantel A, Atkins JN, Giovannucci EL, Meyerhardt JA
• Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).
  PloS one 2018 Guercio BJ, Zhang S, Niedzwiecki D, Li Y, Babic A, Morales-Oyarvide V, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Zoltick ES, …
• Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
  The New England journal of medicine 2018 Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Chen Y, Park JW, Blanc JF, Bolondi L, Klümpen HJ, Chan SL, Zagonel V, Pressiani T, Ryu MH, Venook AP, Hessel C, …
• Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2018 Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S…
• Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2018 Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S…
• Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).
  Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain …
• Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
  JAMA oncology 2018 Van Blarigan EL, Fuchs CS, Niedzwiecki D, Zhang S, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, Ng K, Meyerhardt JA
• Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
  JNCI cancer spectrum 2018 Brown JC, Zhang S, Niedzwiecki D, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Li Y, Zhang X, Ng K, Willett WC, Giovannucci EL, …
• Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
  JAMA 2018 Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ, Alliance for Clinical Trials in …
• Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancer.
  Journal of the National Comprehensive Cancer Network : JNCCN 2018 Grothey A, Venook AP
• Advances in Adjuvant Therapy for Colon Cancer: P value or Practical Value.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Venook AP
• NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
  Journal of the National Comprehensive Cancer Network : JNCCN 2018 Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk …
• Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Fadelu T, Zhang S, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson AB, Atienza DM, Messino M, Kindler HL, Venook A, Ogino S, Ng K, Wu K, Willett W, Giovannucci E, …
• Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance).
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2018 Van Blarigan EL, Fuchs CS, Niedzwiecki D, Ye X, Zhang S, Song M, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, …
• The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal Cancer.
  Oncology (Williston Park, N.Y.) 2017 Ursem C, Venook AP
• Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Ye X, Swanson RS, Enzinger PC, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Gunderson LL, Goldberg RM, Venook AP, Ilson D, O'Reilly E, …
• Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance).
  Journal of geriatric oncology 2017 McCleary NJ, Hubbard J, Mahoney MR, Meyerhardt JA, Sargent D, Venook A, Grothey A
• Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.
  JAMA oncology 2017 Basch E, Dueck AC, Rogak LJ, Minasian LM, Kelly WK, O'Mara AM, Denicoff AM, Seisler D, Atherton PJ, Paskett E, Carey L, Dickler M, Heist RS, Himelstein A, Rugo HS, Sikov WM, Socinski MA, Venook AP, …
• Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.
  Annals of oncology : official journal of the European Society for Medical Oncology 2017 Arnold D, Lueza B, Douillard JY, Peeters M, Lenz HJ, Venook A, Heinemann V, Van Cutsem E, Pignon JP, Tabernero J, Cervantes A, Ciardiello F
• Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
  JAMA 2017 Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM…
• Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).
  Annals of oncology : official journal of the European Society for Medical Oncology 2017 Fuchs MA, Yuan C, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Innocenti F, Warren RS, Bertagnolli MM, Ogino S, …
• NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
  Journal of the National Comprehensive Cancer Network : JNCCN 2017 Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, …
• Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2017 Benson AB, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, …
• Differences in symptom occurrence, severity, and distress ratings between patients with gastrointestinal cancers who received chemotherapy alone or chemotherapy with targeted therapy.
  Journal of gastrointestinal oncology 2017 Tantoy IY, Dhruva A, Cataldo J, Venook A, Cooper BA, Paul SM, Levine JD, Conley YP, Cartwright F, Lee K, Wright F, Miaskowski C
• Reply to L. Casadaban et al.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Niedzwiecki D, Frankel WL, Venook AP, Ye X, Friedman PN, Goldberg RM, Mayer RJ, Colacchio TA, Mulligan JM, Davison TS, O'Brien E, Kerr P, Johnston PG, Kennedy RD, Harkin DP, Schilsky RL, Bertagnolli …
• Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal Cancer.
  Journal of the National Comprehensive Cancer Network : JNCCN 2017 Parikh A, Atreya C, Korn WM, Venook AP
• Right-sided vs left-sided colorectal cancer.
  Clinical advances in hematology & oncology : H&O 2017 Venook AP
• Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference.
  Journal of gastrointestinal oncology 2016 Abou-Alfa GK, Andersen JB, Chapman W, Choti M, Forbes SJ, Gores GJ, Hong TS, Harding JJ, Vander Heiden MG, Javle M, Kelley RK, Kwong LN, Lowery M, Merrell A, Miyabe K, Rhim A, Saha S, Sia D, …
• Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.
  Journal of the National Comprehensive Cancer Network : JNCCN 2016 Atreya CE, Greene C, McWhirter RM, Ikram NS, Allen IE, Van Loon K, Venook AP, Yeh BM, Behr SC
• Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.
  Journal of gastrointestinal oncology 2016 Fidelman N, Kerlan RK, Hawkins RA, Pampaloni M, Taylor AG, Kohi MP, Kolli KP, Atreya CE, Bergsland EK, Kelley RK, Ko AH, Korn WM, Van Loon K, McWhirter RM, Luan J, Johanson C, Venook AP
• Role of Biologics in Colon Cancer: Still Not Clear.
  Journal of oncology practice 2016 Atreya CE, Venook AP
• Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials.
  Pancreas 2016 Kunz PL, Balise RR, Fehrenbacher L, Pan M, Venook AP, Fisher GA, Tempero MA, Ko AH, Korn WM, Hwang J, Bergsland EK
• Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
  JAMA surgery 2016 Katz MH, Shi Q, Ahmad SA, Herman JM, Marsh Rde W, Collisson E, Schwartz L, Frankel W, Martin R, Conway W, Truty M, Kindler H, Lowy AM, Bekaii-Saab T, Philip P, Talamonti M, Cardin D, LoConte N, Shen P…
• Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).
  Cancer medicine 2016 Hatch AJ, Sibley AB, Starr MD, Brady JC, Jiang C, Jia J, Bowers DL, Pang H, Owzar K, Niedzwiecki D, Innocenti F, Venook AP, Hurwitz HI, Nixon AB, Alliance for Clinical Trials in Oncology
• Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.
  Journal of hepatology 2016 Marrero JA, Kudo M, Venook AP, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JH, de Guevara LL, Papandreou C, Takayama T, Sanyal AJ, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R
• Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Niedzwiecki D, Frankel WL, Venook AP, Ye X, Friedman PN, Goldberg RM, Mayer RJ, Colacchio TA, Mulligan JM, Davison TS, O'Brien E, Kerr P, Johnston PG, Kennedy RD, Harkin DP, Schilsky RL, Bertagnolli …
• CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Enzinger PC, Burtness BA, Niedzwiecki D, Ye X, Douglas K, Ilson DH, Villaflor VM, Cohen SJ, Mayer RJ, Venook A, Benson AB, Goldberg RM
• Adjuvant Therapy Trials.
  Cancer journal (Sudbury, Mass.) 2016 Ursem C, Van Loon K, Venook A
• Metastatic Colorectal Cancer: Lessons Learned, Future Possibilities.
  Journal of the National Comprehensive Cancer Network : JNCCN 2016 Venook AP
• A phase II study of axitinib in advanced neuroendocrine tumors.
  Endocrine-related cancer 2016 Strosberg JR, Cives M, Hwang J, Weber T, Nickerson M, Atreya CE, Venook A, Kelley RK, Valone T, Morse B, Coppola D, Bergsland EK
• Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.
  Liver international : official journal of the International Association for the Study of the Liver 2016 Kudo M, Lencioni R, Marrero JA, Venook AP, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JF, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Yoon SK, Nakajima K, Lehr R, Heldner S, …
• Gene Expression Profiling of Evening Fatigue in Women Undergoing Chemotherapy for Breast Cancer.
  Biological research for nursing 2016 Kober KM, Dunn L, Mastick J, Cooper B, Langford D, Melisko M, Venook A, Chen LM, Wright F, Hammer M, Schmidt BL, Levine J, Miaskowski C, Aouizerat BE
• A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.
  Pancreas 2016 Ko AH, LoConte N, Tempero MA, Walker EJ, Kate Kelley R, Lewis S, Chang WC, Kantoff E, Vannier MW, Catenacci DV, Venook AP, Kindler HL
• TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.
  Radiology 2016 Geschwind JF, Kudo M, Marrero JA, Venook AP, Chen XP, Bronowicki JP, Dagher L, Furuse J, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Ye SL, Yoon SK, Nakajima K, Lehr R, Heldner S, …
• NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys.
  Journal of the National Comprehensive Cancer Network : JNCCN 2015 Kurzrock R, Colevas AD, Olszanski A, Akerley W, Arteaga CL, Carson WE, Clark JW, DiPersio JF, Ettinger DS, Morgan RJ, Schwartzberg LS, Venook AP, Gocke CD, Tait J, Stewart FM
• Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Corcoran RB, Atreya CE, Falchook GS, Kwak EL, Ryan DP, Bendell JC, Hamid O, Messersmith WA, Daud A, Kurzrock R, Pierobon M, Sun P, Cunningham E, Little S, Orford K, Motwani M, Bai Y, Patel K, Venook …
• Subgroups of chemotherapy patients with distinct morning and evening fatigue trajectories.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2015 Kober KM, Cooper BA, Paul SM, Dunn LB, Levine JD, Wright F, Hammer MJ, Mastick J, Venook A, Aouizerat BE, Miaskowski C
• The value and effectiveness of angiogenesis inhibitors for colorectal cancer.
  Clinical advances in hematology & oncology : H&O 2015 Venook AP
• Trying to Understand Differing Results of FIRE-3 and 80405: Does the First Treatment Matter More Than Others?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 O'Neil BH, Venook AP
• Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Guercio BJ, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Hu FB, Ogino S, Wu K, Willett WC, Giovannucci EL, …
• A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Ko AH, Bekaii-Saab T, Van Ziffle J, Mirzoeva OM, Joseph NM, Talasaz A, Kuhn P, Tempero MA, Collisson EA, Kelley RK, Venook AP, Dito E, Ong A, Ziyeh S, Courtin R, Linetskaya R, Tahiri S, Korn WM
• On the Verge: Immunotherapy for Colorectal Carcinoma.
  Journal of the National Comprehensive Cancer Network : JNCCN 2015 Oh DY, Venook AP, Fong L
• Rectal Cancer, Version 2.2015.
  Journal of the National Comprehensive Cancer Network : JNCCN 2015 Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Grothey A, Hochster HS, Hunt S, Kamel A, Kirilcuk N, Leong LA, Lin E, …
• Special Series: Advances in GI Cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Meyerhardt JA, Tepper JE, Venook AP
• Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
  BMC cancer 2015 Kelley RK, Magbanua MJ, Butler TM, Collisson EA, Hwang J, Sidiropoulos N, Evason K, McWhirter RM, Hameed B, Wayne EM, Yao FY, Venook AP, Park JW
• Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.
  Liver cancer 2015 Siegel AB, El-Khoueiry AB, Finn RS, Guthrie KA, Goyal A, Venook AP, Blanke CD, Verna EC, Dove L, Emond J, Kato T, Samstein B, Busuttil R, Remotti H, Coffey A, Brown RS
• Bevacizumab vs EGFR antibodies in metastatic colorectal cancer.
  Clinical advances in hematology & oncology : H&O 2015 Venook AP
• Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Masters GA, Krilov L, Bailey HH, Brose MS, Burstein H, Diller LR, Dizon DS, Fine HA, Kalemkerian GP, Moasser M, Neuss MN, O'Day SJ, Odenike O, Ryan CJ, Schilsky RL, Schwartz GK, Venook AP, Wong SL, …
• Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Daud AI, Ashworth MT, Strosberg J, Goldman JW, Mendelson D, Springett G, Venook AP, Loechner S, Rosen LS, Shanahan F, Parry D, Shumway S, Grabowsky JA, Freshwater T, Sorge C, Kang SP, Isaacs R, …
• Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).
  Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Cushman SM, Jiang C, Hatch AJ, Shterev I, Sibley AB, Niedzwiecki D, Venook AP, Owzar K, Hurwitz HI, Nixon AB
• A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma.
  Anticancer research 2014 Cinar P, Calkins SM, Venook AP, Kelley RK
• Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
  Journal of the National Cancer Institute 2014 Ng K, Meyerhardt JA, Chan AT, Sato K, Chan JA, Niedzwiecki D, Saltz LB, Mayer RJ, Benson AB, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Venook AP, Ogino S, Giovannucci EL, Fuchs CS
• Bone metastases and skeletal-related events from neuroendocrine tumors.
  Endocrine connections 2014 Van Loon K, Zhang L, Keiser J, Carrasco C, Glass K, Ramirez MT, Bobiak S, Nakakura EK, Venook AP, Shah MH, Bergsland EK
• Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
  Journal of the National Cancer Institute 2014 Lamont EB, Schilsky RL, He Y, Muss H, Cohen HJ, Hurria A, Meilleur A, Kindler HL, Venook A, Lilenbaum R, Niell H, Goldberg RM, Joffe S, Alliance for Clinical Trials in Oncology
• Progression-free survival: helpful biomarker or clinically meaningless end point?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Venook AP, Tabernero J
• NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.
  Journal of the National Comprehensive Cancer Network : JNCCN 2014 Venook AP, Arcila ME, Benson AB, Berry DA, Camidge DR, Carlson RW, Choueiri TK, Guild V, Kalemkerian GP, Kurzrock R, Lovly CM, McKee AE, Morgan RJ, Olszanski AJ, Redman MW, Stearns V, McClure J, …
• Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.
  International journal of cancer 2014 Song EK, Tai WM, Messersmith WA, Bagby S, Purkey A, Quackenbush KS, Pitts TM, Wang G, Blatchford P, Yahn R, Kaplan J, Tan AC, Atreya CE, Eckhardt G, Kelley RK, Venook A, Kwak EL, Ryan D, Arcaroli JJ
• 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).
  Journal of the National Cancer Institute 2014 Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, O'Reilly EM, Fuchs C, Innocenti F, Venook AP, Alliance for Clinical Trials in Oncology
• Hepatobiliary cancers, version 2.2014.
  Journal of the National Comprehensive Cancer Network : JNCCN 2014 Benson AB, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, …
• Colon cancer, version 3.2014.
  Journal of the National Comprehensive Cancer Network : JNCCN 2014 Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, Messersmith W, Mulcahy MF, Murphy JD, Nurkin …
• Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance).
  PloS one 2014 Fuchs MA, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Wu K, Willett WC, Giovannucci EL, Meyerhardt JA
• 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.
  Journal of gastrointestinal cancer 2014 Fidelman N, Kerlan RK, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP
• CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
  Gastroenterology 2014 Shiovitz S, Bertagnolli MM, Renfro LA, Nam E, Foster NR, Dzieciatkowski S, Luo Y, Lao VV, Monnat RJ, Emond MJ, Maizels N, Niedzwiecki D, Goldberg RM, Saltz LB, Venook A, Warren RS, Grady WM, Alliance …
• International adaptations of NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2014 Carlson RW, Larsen JK, McClure J, Fitzgerald CL, Venook AP, Benson AB, Anderson BO
• Progress against GI cancer during the American Society of Clinical Oncology's first 50 years.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Mayer RJ, Venook AP, Schilsky RL
• American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE
• Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicities.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Van Loon K, Venook AP
• Colorectal cancer: all hands on deck.
  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2014 Venook AP, Weiser MR, Tepper JE
• A review of hepatocellular carcinoma (HCC) staging systems.
  Chinese clinical oncology 2013 Subramaniam S, Kelley RK, Venook AP
• Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance).
  Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Nixon AB, Pang H, Starr MD, Friedman PN, Bertagnolli MM, Kindler HL, Goldberg RM, Venook AP, Hurwitz HI, Alliance for Clinical Trials In Oncology
• A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.
  British journal of cancer 2013 Kelley RK, Hwang J, Magbanua MJ, Watt L, Beumer JH, Christner SM, Baruchel S, Wu B, Fong L, Yeh BM, Moore AP, Ko AH, Korn WM, Rajpal S, Park JW, Tempero MA, Venook AP, Bergsland EK
• Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance.
  Clinical colorectal cancer 2013 Jeon J, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Atienza D, Messino M, Kindler H, Venook A, Fuchs CS, Meyerhardt JA
• Biomarkers in colon cancer: the chasm between expectations and reality.
  Oncology (Williston Park, N.Y.) 2013 Van Loon K, Venook AP
• The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?
  The Lancet. Oncology 2013 Abou-Alfa GK, Venook AP
• Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
  Journal of the National Comprehensive Cancer Network : JNCCN 2013 Benson AB, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren…
• Predictive biomarkers for bevacizumab: are we there yet?
  Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Maru D, Venook AP, Ellis LM
• Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Venook AP, Niedzwiecki D, Lopatin M, Ye X, Lee M, Friedman PN, Frankel W, Clark-Langone K, Millward C, Shak S, Goldberg RM, Mahmoud NN, Warren RS, Schilsky RL, Bertagnolli MM
• Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.
  Annals of oncology : official journal of the European Society for Medical Oncology 2013 Kelley RK, Nimeiri HS, Munster PN, Vergo MT, Huang Y, Li CM, Hwang J, Mulcahy MF, Yeh BM, Kuhn P, Luttgen MS, Grabowsky JA, Stucky-Marshall L, Korn WM, Ko AH, Bergsland EK, Benson AB, Venook AP
• Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.
  Annals of surgical oncology 2013 Katz MH, Marsh R, Herman JM, Shi Q, Collison E, Venook AP, Kindler HL, Alberts SR, Philip P, Lowy AM, Pisters PW, Posner MC, Berlin JD, Ahmad SA
• Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
  Journal of the National Comprehensive Cancer Network : JNCCN 2013 Benson AB, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren…
• Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405.
  Clinical colorectal cancer 2013 Van Loon K, Wigler D, Niedzwiecki D, Venook AP, Fuchs C, Blanke C, Saltz L, Goldberg RM, Meyerhardt JA
• Biologic agents in the treatment of colorectal cancer: the last decade; the lost decade?
  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2013 Venook AP, Saltz LB
• Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.
  Gastrointestinal cancer research : GCR 2013 Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O'Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, Dematteo RP, Venook…
• Novel therapeutics in hepatocellular carcinoma: how can we make progress?
  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2013 Kelley RK, Venook AP
• Rectal cancer.
  Journal of the National Comprehensive Cancer Network : JNCCN 2012 Benson AB, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fuchs CS, Grem JL, Hunt S, Leong LA, Lin E, Martin MG, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan …
• Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
  Journal of the National Cancer Institute 2012 Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Venook A, Fuchs CS
• Counterpoint: Adjuvant therapy in stage II colon cancer: pain not justified by the gain.
  Journal of the National Comprehensive Cancer Network : JNCCN 2012 Van Loon K, Venook AP
• Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas.
  American journal of clinical oncology 2012 Ko AH, Espinoza AM, Jones KA, Venook AP, Bergsland EK, Kelley RK, Dito E, Ong A, Hanover CS, Coakley FV, Tempero MA
• When progressive disease does not mean treatment failure: reconsidering the criteria for progression.
  Journal of the National Cancer Institute 2012 Oxnard GR, Morris MJ, Hodi FS, Baker LH, Kris MG, Venook AP, Schwartz LH
• Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
  Pancreas 2012 Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, Nakakura EK
• Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012 Kelley RK, Hirose R, Venook AP
• Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.
  Journal of the National Comprehensive Cancer Network : JNCCN 2012 Benson AB, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fakih MG, Fleshman JW, Fuchs CS, Grem JL, Leong LA, Lin E, May KS, Mulcahy MF, …
• Metastatic colorectal cancer: a curable disease.
  Oncology (Williston Park, N.Y.) 2012 Van Loon K, Venook AP
• Predictive biomarkers in advance of a companion drug: ahead of their time?
  Journal of the National Comprehensive Cancer Network : JNCCN 2012 Kelley RK, Atreya C, Venook AP, Febbo PG
• Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel.
  Journal of vascular and interventional radiology : JVIR 2012 Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST
• Is there currently an established role for the use of predictive or prognostic molecular markers in the management of colorectal cancer? A point/counterpoint.
  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2012 Venook AP, Bendell JC, Warren RS
• Biomarker use in colorectal cancer therapy.
  Journal of the National Comprehensive Cancer Network : JNCCN 2011 Kelley RK, Wang G, Venook AP
• Colon cancer.
  Journal of the National Comprehensive Cancer Network : JNCCN 2011 Benson AB, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fleshman JW, Fuchs CS, Grem JL, Knol JA, Leong LA, Lin E, May KS, Mulcahy MF, …
• Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
  Journal of the National Cancer Institute 2011 Ng K, Ogino S, Meyerhardt JA, Chan JA, Chan AT, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Benson AB, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Bertagnolli MM, Venook AP, Fuchs CS
• Adjuvant treatment of colon cancer: what is next?
  Current opinion in oncology 2011 Van Loon K, Venook AP
• Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303).
  Cancer 2011 Roberts AS, Campa MJ, Gottlin EB, Jiang C, Owzar K, Kindler HL, Venook AP, Goldberg RM, O'Reilly EM, Patz EF
• Lactic acidosis and colon cancer: oncologic emergency?
  Clinical colorectal cancer 2011 Espinoza AM, Venook AP
• Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?
  Clinical colorectal cancer 2011 Kelley RK, Venook AP
• Long-term outcome of early-stage rectal cancer undergoing standard resection and local excision.
  Clinical colorectal cancer 2011 Peng J, Chen W, Venook AP, Sheng W, Xu Y, Guan Z, Cai G, Cai S
• "And what other medications are you taking?".
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Gordan JD, Chay WY, Kelley RK, Ko AH, Choo SP, Venook AP
• Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer.
  Journal of the National Comprehensive Cancer Network : JNCCN 2011 Kelley RK, Van Bebber SL, Phillips KA, Venook AP
• Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect.
  Cancer 2010 Peng J, Sheng W, Huang D, Venook AP, Xu Y, Guan Z, Cai S
• Nonadherence to imatinib during an economic downturn.
  The New England journal of medicine 2010 Kelley RK, Venook AP
• Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, Gores G, Kerlan R, Merle P, O'Neil B, Poon R, Schwartz L, Tepper J, Yao F, Haller D, Mooney M, Venook A
• Hepatocellular carcinoma: Ablate and wait versus rapid transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2010 Roberts JP, Venook A, Kerlan R, Yao F
• Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study.
  International journal of clinical practice 2010 Lencioni R, Marrero J, Venook A, Ye SL, Kudo M
• Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.
  HPB : the official journal of the International Hepato Pancreato Biliary Association 2010 Schwarz RE, Abou-Alfa GK, Geschwind JF, Krishnan S, Salem R, Venook AP, American Hepato-Pancreato-Biliary Association, Society of Surgical Oncology, Society for Surgery of the Alimentary Tract
• Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Chung KY, Gore I, Fong L, Venook A, Beck SB, Dorazio P, Criscitiello PJ, Healey DI, Huang B, Gomez-Navarro J, Saltz LB
• Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
  Archives of surgery (Chicago, Ill. : 1960) 2010 Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, Nakakura EK
• A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.
  Cancer chemotherapy and pharmacology 2010 Ko AH, Venook AP, Bergsland EK, Kelley RK, Korn WM, Dito E, Schillinger B, Scott J, Hwang J, Tempero MA
• NCCN clinical practice guidelines in oncology. Anal carcinoma.
  Journal of the National Comprehensive Cancer Network : JNCCN 2010 Engstrom PF, Arnoletti JP, Benson AB, Berlin JD, Berry JM, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Knol JA, Leong LA, Lin E, Mulcahy …
• The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.
  The oncologist 2010 Venook AP, Papandreou C, Furuse J, de Guevara LL
• Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
  The oncologist 2010 Lencioni R, Chen XP, Dagher L, Venook AP
• NCCN Clinical Practice Guidelines in Oncology: colon cancer.
  Journal of the National Comprehensive Cancer Network : JNCCN 2009 Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, …
• NCCN Clinical Practice Guidelines in Oncology: rectal cancer.
  Journal of the National Comprehensive Cancer Network : JNCCN 2009 Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, …
• Drug development in advanced colorectal cancer: challenges and opportunities.
  Current oncology reports 2009 Kelley R, Venook AP
• NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
  Journal of the National Comprehensive Cancer Network : JNCCN 2009 Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marrero J, Meranze SG, Mulvihill SJ, Park…
• A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher.
  Gastrointestinal cancer research : GCR 2009 Shah U, O'Neil B, Allen J, Goldberg RM, Bernard S, Moore D, Venook AP, Morse MM
• Design issues in dose-finding Phase I trials for combinations of two agents.
  Journal of biopharmaceutical statistics 2009 Fan SK, Venook AP, Lu Y
• Sorafenib in hepatocellular carcinoma: separating the hype from the hope.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Kelley RK, Venook AP
• Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy.
  Pancreas 2008 Wong D, Ko AH, Hwang J, Venook AP, Bergsland EK, Tempero MA
• Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008 Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M
• NCCN Task Force Report: mTOR inhibition in solid tumors.
  Journal of the National Comprehensive Cancer Network : JNCCN 2008 Figlin RA, Brown E, Armstrong AJ, Akerley W, Benson AB, Burstein HJ, Ettinger DS, Febbo PG, Fury MG, Hudes GR, Kies MS, Kwak EL, Morgan RJ, Mortimer J, Reckamp K, Venook AP, Worden F, Yen Y
• The impact of new data in the treatment of advanced hepatocellular carcinoma.
  Current oncology reports 2008 Abou-Alfa GK, Venook AP
• A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?
  Investigational new drugs 2008 Ko AH, Dito E, Schillinger B, Venook AP, Xu Z, Bergsland EK, Wong D, Scott J, Hwang J, Tempero MA
• Responding to the rising incidence of hepatocellular carcinoma with targeted therapy.
  Gastrointestinal cancer research : GCR 2008 Choo SP, Venook AP
• Excess toxicity associated with docetaxel and irinotecan in patients with metastatic, gemcitabine-refractory pancreatic cancer: results of a phase II study.
  Cancer investigation 2008 Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA
• Phase II trial of T138067, a novel microtubule inhibitor, in patients with metastatic, refractory colorectal carcinoma.
  Clinical colorectal cancer 2008 Berlin JD, Venook A, Bergsland E, Rothenberg M, Lockhart AC, Rosen L
• Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.
  The oncologist 2007 O'Neil BH, Venook AP
• A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
  Annals of surgical oncology 2007 Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, Schilsky RL, Goldberg RM, Mayer RJ
• Section I: essentials of ensuring excellence in cancer care.
  Gastrointestinal cancer research : GCR 2007 Goldberg RM, Marshall JL, Kachnic LA, Venook AP
• Section III: Treatment of Advanced Gastrointestinal Cancers.
  Gastrointestinal cancer research : GCR 2007 Hochster HS, O'Reilly EM, Ajani JA, Venook AP
• Section IV: Significance of Recent Study Results and Future Research Directions in Gastrointestinal Oncology.
  Gastrointestinal cancer research : GCR 2007 Goldberg RM, Marshall JL, Ajani JA, Philip PA, O'Reilly EM, Venook AP
• Colon cancer.
  Journal of the National Comprehensive Cancer Network : JNCCN 2007 Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saltz L, Shibata D, …
• Rectal cancer.
  Journal of the National Comprehensive Cancer Network : JNCCN 2007 Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saltz L, Shibata D, …
• Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides.
  Journal of immunotherapy (Hagerstown, Md. : 1997) 2007 Kavanagh B, Ko A, Venook A, Margolin K, Zeh H, Lotze M, Schillinger B, Liu W, Lu Y, Mitsky P, Schilling M, Bercovici N, Loudovaris M, Guillermo R, Lee SM, Bender J, Mills B, Fong L
• An alternative therapy for patients with hepatic impairment?
  Onkologie 2007 Choo SP, Venook AP
• Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer.
  Cancer 2007 Hecht JR, Patnaik A, Berlin J, Venook A, Malik I, Tchekmedyian S, Navale L, Amado RG, Meropol NJ
• End points in advanced colon cancer clinical trials: a review and proposal.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Allegra C, Blanke C, Buyse M, Goldberg R, Grothey A, Meropol NJ, Saltz L, Venook A, Yothers G, Sargent D
• Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
  The American journal of gastroenterology 2007 Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, Satomura S, Schwartz ME
• Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
  Surgical oncology clinics of North America 2007 Nakakura EK, Venook AP, Bergsland EK
• Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.
  Clinical colorectal cancer 2007 Venook AP, Blanke CD, Niedzwiecki D, Lenz HJ, Taylor JR, Hollis DR, Sutherland S, Goldberg RM
• A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer.
  International journal of radiation oncology, biology, physics 2007 Ko AH, Quivey JM, Venook AP, Bergsland EK, Dito E, Schillinger B, Tempero MA
• Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver.
  Clinical imaging 2007 Qayyum A, Lee GK, Yeh BM, Allen JN, Venook AP, Coakley FV
• Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement.
  Annals of surgical oncology 2006 Bartlett DL, Berlin J, Lauwers GY, Messersmith WA, Petrelli NJ, Venook AP
• Hepatobiliary cancers. Clinical practice guidelines in oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2006 Benson AB, Bekaii-Saab T, Ben-Josef E, Blumgart L, Clary BM, Curley SA, Davila R, Earle CC, Ensminger WD, Gibbs JF, Laheru D, Langnas AN, Mulvihill SJ, Nemcek AA, Posey JA, Sigurdson ER, Sinanan M, …
• Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS
• The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Ratain MJ, Miller AA, McLeod HL, Venook AP, Egorin MJ, Schilsky RL
• Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
  Cancer gene therapy 2006 Atencio IA, Grace M, Bordens R, Fritz M, Horowitz JA, Hutchins B, Indelicato S, Jacobs S, Kolz K, Maneval D, Musco ML, Shinoda J, Venook A, Wen S, Warren R
• Targeted therapy in colorectal cancer.
  Clinical advances in hematology & oncology : H&O 2006 Rajpal S, Venook AP
• Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA
• Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.
  Clinical colorectal cancer 2005 Venook AP, Blanke CD, Niedzwiecki D, Lenz HJ, Taylor JR, Hollis DR, Sutherland S, Goldberg RM
• Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.
  British journal of cancer 2005 Ko AH, Hwang J, Venook AP, Abbruzzese JL, Bergsland EK, Tempero MA
• Anal canal cancer clinical practice guidelines in oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2005 Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, …
• Colon cancer clinical practice guidelines in oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2005 Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, …
• Rectal cancer clinical practice guidelines in oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2005 Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, …
• Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.
  Cancer 2005 Venook AP
• Critical evaluation of current treatments in metastatic colorectal cancer.
  The oncologist 2005 Venook A
• The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005 Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP
• Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM
• Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
  Seminars in oncology 2004 Alberts DS, Muggia FM, Carmichael J, Winer EP, Jahanzeb M, Venook AP, Skubitz KM, Rivera E, Sparano JA, DiBella NJ, Stewart SJ, Kavanagh JJ, Gabizon AA
• Cetuximab in the treatment of colorectal cancer.
  Clinical advances in hematology & oncology : H&O 2004 Goldberg RM, Venook AP, Schilsky RL
• Regional therapy of liver metastases.
  Current treatment options in oncology 2004 Whisenant J, Venook A
• Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.
  Journal of the National Comprehensive Cancer Network : JNCCN 2004 Venook AP
• Key research issues in the management of hepatocellular carcinoma.
  Cancer chemotherapy and pharmacology 2004 Venook AP
• Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer.
  Oncology (Williston Park, N.Y.) 2004 Whisenant J, Venook A
• Hepatocellular carcinoma: epidemic and treatment.
  Current oncology reports 2004 Allen J, Venook A
• Reactivation of hepatitis C virus after chemotherapy for colon cancer.
  Clinical oncology (Royal College of Radiologists (Great Britain)) 2004 Melisko ME, Fox R, Venook A
• Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
  Radiology 2004 Wilson MW, Kerlan RK, Fidelman NA, Venook AP, LaBerge JM, Koda J, Gordon RL
• A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863.
  Annals of oncology : official journal of the European Society for Medical Oncology 2003 Venook AP, Enders Klein C, Fleming G, Hollis D, Leichman CG, Hohl R, Byrd J, Budman D, Villalona M, Marshall J, Rosner GL, Ramirez J, Kastrissios H, Ratain MJ
• Colorectal metastases confined to the liver: a unique opportunity?
  Seminars in oncology 2003 Venook AP
• Induction therapy in patients with metastatic colorectal cancer.
  Seminars in oncology 2003 Venook AP
• Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal.
  Surgical oncology 2003 Visser BC, Venook AP, Patti MG
• Testing the water before diving off the cutting edge.
  Annals of surgical oncology 2003 Venook AP
• Shedding old paradigms: developing viruses to treat cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 Bergsland EK, Venook AP
• Therapeutic approaches to metastasis confined to the liver.
  Current oncology reports 2001 Venook AP, Warren RS
• Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.
  Gene therapy 2001 Mulvihill S, Warren R, Venook A, Adler A, Randlev B, Heise C, Kirn D
• Hepatocellular carcinoma.
  Current treatment options in oncology 2000 Venook AP
• Hepatocellular carcinoma.
  Current opinion in oncology 2000 Bergsland EK, Venook AP
• Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ
• Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
  The New England journal of medicine 2000 Venook AP, Althaus B, Warren RS
• Regional strategies for managing hepatocellular carcinoma.
  Oncology (Williston Park, N.Y.) 2000 Venook AP
• Transcatheter embolization for the treatment of misperfusion after hepatic artery chemoinfusion pump implantation.
  Annals of surgical oncology 1999 Bloom AI, Gordon RL, Ahl KH, Kerlan RK, LaBerge JM, Wilson MW, Venook AP, Warren R
• Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999 Rubin J, Ajani J, Schirmer W, Venook AP, Bukowski R, Pommier R, Saltz L, Dandona P, Anthony L
• Embolization and chemoembolization therapy for neuroendocrine tumors.
  Current opinion in oncology 1999 Venook AP
• Tamoxifen in liver disease: potential exacerbation of hepatic dysfunction.
  Annals of oncology : official journal of the European Society for Medical Oncology 1998 Floren LC, Hebert MF, Venook AP, Jordan VC, Cisneros A, Somberg KA
• Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998 Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL
• Update on hepatic intra-arterial chemotherapy.
  Oncology (Williston Park, N.Y.) 1997 Venook AP
• Can a vitamin prevent hepatocellular carcinoma?
  Hepatology (Baltimore, Md.) 1997 Venook AP
• Intra-abdominal desmoplastic small round-cell tumor: expansion of the pathologic profile.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1996 Dorsey BV, Benjamin LE, Rauscher F, Klencke B, Venook AP, Warren RS, Weidner N
• Practice guidelines for colorectal cancer.
  The cancer journal from Scientific American 1996 Venook A, Goodnight J, Kumar S, Taylor C, Gilden R, Figlin RA
• Practice guidelines for esophageal cancer.
  The cancer journal from Scientific American 1996 Goodnight J, Venook A, Ames M, Taylor C, Gilden R, Figlin RA
• Practice guidelines for gastric cancer.
  The cancer journal from Scientific American 1996 Venook A, Goodnight J, Smith NG, Taylor C, Gilden R, Figlin RA
• Practice guidelines for pancreatic cancer.
  The cancer journal from Scientific American 1996 Goodnight J, Venook A, Fringer J, Taylor C, Gilden R, Figlin RA
• Regional chemotherapy approaches for primary and metastatic liver tumors.
  Surgical oncology clinics of North America 1996 Venook AP, Warren RS
• Pulmonary aspergillosis masquerading as progressive post-transplant lymphoma.
  Transplant international : official journal of the European Society for Organ Transplantation 1996 Kirn D, Venook A, Pena I
• Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization.
  Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1995 Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL, Lake JR
• Treatment of hepatocellular carcinoma: too many options?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994 Venook AP
• Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.
  Cancer 1993 Small EJ, Venook AP, Damon LE
• Liver transplantation for hepatocellular carcinoma.
  Hepatology (Baltimore, Md.) 1993 Venook AP
• A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.
  Cancer 1993 Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ
• The Sweet syndrome during therapy with granulocyte colony-stimulating factor.
  Annals of internal medicine 1992 Park JW, Mehrotra B, Barnett BO, Baron AD, Venook AP
• Hepatic cancers and their response to chemoembolization therapy. Quantitative image-guided 31P magnetic resonance spectroscopy.
  Investigative radiology 1992 Meyerhoff DJ, Karczmar GS, Valone F, Venook A, Matson GB, Weiner MW
• Hepatic intra-arterial methylene blue injection during endoscopy: a method of detecting gastroduodenal misperfusion in patients receiving hepatic intra-arterial chemotherapy via an implanted pump.
  Gastrointestinal endoscopy 1992 Frye JW, Venook AP, Ostroff JW, Mulvihill SJ, Warren RS, Pellegrini CA, Ring EJ, Stagg RJ
• Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.
  Journal of the National Cancer Institute 1991 Stagg RJ, Venook AP, Chase JL, Lewis BJ, Warren RS, Roh M, Mulvihill SJ, Grobman BJ, Rayner AA, Hohn DC
• Chemoembolization for hepatocellular carcinoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990 Venook AP, Stagg RJ, Lewis BJ, Chase JL, Ring EJ, Maroney TP, Hohn DC
• Activity of coumarin and cimetidine in metastatic renal cell carcinoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989 Venook AP, Davenport Y, Tseng A
• Elevated plasma tamoxifen levels in a patient with liver obstruction.
  Cancer chemotherapy and pharmacology 1989 DeGregorio MW, Wiebe VJ, Venook AP, Holleran WM
• Regional chemotherapy for colorectal cancer metastatic to the liver.
  Oncology (Williston Park, N.Y.) 1988 Venook AP, Stagg RJ, Lewis BJ
• Pentoxifylline and aplastic anemia.
  Annals of internal medicine 1987 Mass RD, Venook AP, Linker CA, Zipkin RE
• Prophylactic heparin in APL.
  Blood 1987 Venook AP, Shuman MA, Corash L
• Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987 Venook AP, Tseng A, Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD
• Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing.
  Journal of general internal medicine 1987 White RH, Hong R, Venook AP, Daschbach MM, Murray W, Mungall DR, Coleman RW